Skip to Main Content

The Rockefeller University Hospital

Site Map Investigators Log-in
Search results for
  1. (JKR-0338) A study to determine how well skin with psoriasis vulgaris improves with a specific wavelength of UVB (narrowband) light therapy in persons with dark skin tones

  2. (JKR-0511) A Phase III study to help understand the action of the drug Efalizumab, trade name Raptiva , for the adult patient with moderate to severe plaque psoriasis and who is a candidate for internal medications

  3. (JKR-0179) Screening for entry into psoriasis studies

  4. (JKR-0397) Collection of blood specimens for research purposes

  5. (JKR-0442) A study to document the natural course and history of psoriasis before, during and after treatment with conventional therapies

  6. (JKR-0491) Skin biopsy for analysis of cell growth, cell differentiation and inflammation in the skin

  7. (JKR-0603) Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis

  8. (JKR-0608)A comparative study of tools used to measure the severity of psoriasis and response to therapy

  9. (JKR-0336) Use of humanized CD25 (DaclizumabTM) monoclonal

  10. (JKR-0337) Use of Humanized CD25 (anti-TAC) Monoclonal Antibody/Placebo to Prevent Relapse of Psoriasis Vulgaris Following NB-UVB Therapy

  11. (JKR-0542) Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects with Psoriasis

  12. (JKR-0622) The Natural History of Pigmented Skin Lesions

  13. (JKR-0653) Safety and Tolerability of the Investigational Medicine AbGn-168 in the Treatment of Chronic Plaque Psoriasis

  14. (JKR-0663) A study to evaluate reversal of the pathological epidermal phenotype in severe AD with suppression of immune activation during cyclosporine A therapy

  15. (JKR-0641) A study to document the natural history of atopic dermatitis before, during, and after treatment with conventional therapies

  16. (JKR-0671) A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

  17. (JKR-0686) Screening for Entry into Skin Disease Studies

  18. (JKR-0716) SRT2104 in Subjects with Moderate to Severe Plaque-Type Psoriasis

  19. (JKR-0742) DPCP in Normal Volunteers

  20. (JKR-0744) Phase 3, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of 2 oral doses of CP-690,550 in subjects with moderate to severe chronic plaque psoriasis

  21. (JKR-0782) Exploratory Approach to Study Keloid Formation in Human Skin

  22. (JKR-0772) LY2439821 in Patients with Moderate-to-Severe Plaque Psoriasis

  23. (JKR-0937) Secukinumab in Mild Psoriasis